Kim D., Kim R. G., Kim H. S., Kim J. M., Jun S. C., Lee B., Jo H. J., Rosa-Neto P., Lee M. C., Kim H. I. (2014). Longitudinal changes in resting-state brain activity in a capsular infarct model, J Cereb Blood Flow Metab. En savoir plus.

Kim H. S., Kim D., Kim R. G., Kim J. M., Chung E., Rosa-Neto P., Lee M. C., Kim H. I. (2014). A rat model of photothrombotic capsular infarct with a marked motor deficit: a behavioral, histologic, and microPET study, J Cereb Blood Flow Metab, 34(4), 683-9. En savoir plus.

Lataster J., Collip D., Ceccarini J., Hernaus D., Haas D., Booij L., van Os J., Pruessner J., Van Laere K., Myin-Germeys I. (2014). Familial liability to psychosis is associated with attenuated dopamine stress signaling in ventromedial prefrontal cortex, Schizophr Bull, 40(1), 66-77. En savoir plus.

Ledoux A. A., Boyer P., Phillips J. L., Labelle A., Smith A., Bohbot V. (2014). Structural hippocampal anomalies in a schizophrenia population correlate with navigation performance on a wayfinding task, Front Behav Neurosci, 8, 88. En savoir plus.

Leduc V., De Beaumont L., Theroux L., Dea D., Aisen P., Petersen R. C., Dufour R., Poirier J. (2014). HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study, Mol Psychiatry. En savoir plus.

Leuzy A., Zimmer E. R., Bhat V., Rosa-Neto P., Gauthier S. (2014). Imaging biomarkers for amyloid: a new generation of probes and what lies ahead, Int Psychogeriatr, 26(5), 703-7. En savoir plus.

Leuzy A., Zimmer E. R., Heurling K., Rosa-Neto P., Gauthier S. (2014). Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues, Amyloid, 21(3), 143-8. En savoir plus.

Liu S. Y., Wrosch C., Miller G. E., Pruessner J. (2014). Self-esteem change and diurnal cortisol secretion in older adulthood, Psychoneuroendocrinology, 41, 111-20. En savoir plus.

Liu Z., Zhou J., Li Y., Hu F., Lu Y., Ma M., Feng Q., Zhang J. E., Wang D., Zeng J., Bao J., Kim J. Y., Chen Z. F., El Mestikawy S., Luo M. (2014). Dorsal raphe neurons signal reward through 5-HT and glutamate, Neuron, 81(6), 1360-74. En savoir plus.

Lopez J. P., Lim R., Cruceanu C., Crapper L., Fasano C., Labonte B., Maussion G., Yang J. P., Yerko V., Vigneault E., El Mestikawy S., Mechawar N., Pavlidis P., Turecki G. (2014). miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment, Nat Med, 20(7), 764-8. En savoir plus.

Lucassen P. J., Pruessner J., Sousa N., Almeida O. F., Van Dam A. M., Rajkowska G., Swaab D. F., Czeh B. (2014). Neuropathology of stress, Acta Neuropathol, 127(1), 109-35. En savoir plus.

Luck T., Riedel-Heller S. G., Luppa M., Wiese B., Bachmann C., Jessen F., Bickel H., Weyerer S., Pentzek M., Konig H. H., Prokein J., Eisele M., Wagner M., Mosch E., Werle J., Fuchs A., Brettschneider C., Scherer M., Breitner J., Maier W. (2014). A hierarchy of predictors for dementia-free survival in old-age: results of the AgeCoDe study, Acta Psychiatr Scand. En savoir plus.

Ma W., Quirion R. (2014). Targeting cell surface trafficking of pain-facilitating receptors to treat chronic pain conditions, Expert Opin Ther Targets, 18(4), 459-72. En savoir plus.

Magon S., Chakravarty M., Amann M., Weier K., Naegelin Y., Andelova M., Radue E. W., Stippich C., Lerch J. P., Kappos L., Sprenger T. (2014). Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: the impact of thalamic subnuclei on disability, Hum Brain Mapp, 35(8), 4193-203. En savoir plus.

Magon S., Gaetano L., Chakravarty M., Lerch J. P., Naegelin Y., Stippich C., Kappos L., Radue E. W., Sprenger T. (2014). White matter lesion filling improves the accuracy of cortical thickness measurements in multiple sclerosis patients: a longitudinal study, BMC Neurosci, 15, 106. En savoir plus.

Maillet D., Rajah M. (2014). Dissociable roles of default-mode regions during episodic encoding, NeuroImage, 89, 244-55. En savoir plus.

Maillet D., Rajah M. (2014). Age-related differences in brain activity in the subsequent memory paradigm: a meta-analysis, Neurosci Biobehav Rev, 45, 246-57. En savoir plus.

Menard C., Herzog H., Schwarzer C., Quirion R. (2014). Possible role of dynorphins in Alzheimer's disease and age-related cognitive deficits, Neurodegener Dis, 13(2-3), 82-5. En savoir plus.

Menard C., Quirion R., Bouchard S., Ferland G., Gaudreau P. (2014). Glutamatergic signaling and low prodynorphin expression are associated with intact memory and reduced anxiety in rat models of healthy aging, Front Aging Neurosci, 6, 81. En savoir plus.

Milella M. S., Marengo L., Larcher K., Fotros A., Dagher A., Rosa-Neto P., Benkelfat C., Leyton M. (2014). Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study, NeuroImage, 98, 195-202. En savoir plus.